Skip to main content
Caplight Logo









Defense Threat Reduction Agency

Defense Threat Reduction Agency

Fort Belvoir, Virginiadtra.mil

Overview

The Defense Threat Reduction Agency is a United States Department of Defense agency that provides grants and contracts to counter weapons of mass destruction and emerging threats.

Year Founded

1998

Portfolio Companies

34

Website

dtra.mil

Investments

Defense Threat Reduction Agency investments
CompanyDateStageLead
Spero BiopharmaJul 2018GrantCo-investor
Primmune TherapeuticsMar 2024GrantCo-investor
Saltenna LLC-GrantCo-investor
EsperovaxDec 2024GrantCo-investor
PrenosisNov 2021GrantCo-investor
Book a demo to see all 34 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Defense Threat Reduction Agency based?

Defense Threat Reduction Agency is headquartered in Fort Belvoir, Virginia, United States.

When was Defense Threat Reduction Agency founded?

Defense Threat Reduction Agency was founded in 1998.

How many portfolio companies does Defense Threat Reduction Agency have?

Defense Threat Reduction Agency has 34 portfolio companies in Caplight's dataset.

What are some companies in Defense Threat Reduction Agency's portfolio?

Portfolio companies visible on Caplight include Spero Biopharma, Primmune Therapeutics, Saltenna LLC, Esperovax, Prenosis.

What was Defense Threat Reduction Agency's most recent investment shown here?

Defense Threat Reduction Agency's most recent investment in this portfolio sample was in Esperovax in 2024.

What sectors does Defense Threat Reduction Agency focus on?

Defense Threat Reduction Agency focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Cybersecurity, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Telecommunications & Networking, Cybersecurity, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech.

What company stages does Defense Threat Reduction Agency focus on?

Defense Threat Reduction Agency typically invests at the MultiStage stage.

Firmographic Details

HeadquartersFort Belvoir, Virginia
Year Founded1998

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?